What’s next for Richter’s syndrome?
Results of Phase Ib/II study of ricolinostat in multiple myeloma
Improving T-cell therapy with antigen specific T-cells
CLL therapy - current status and issues
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib